top of page

Aktuelles

Veröffentlichung über Walter Brendel in Frontiers in Transplantation

Walter Brendel was a physiologist who headed the Institut of Experimental Surgery at the University of Munich (LMU) from 1961 until 1989. His legendary career began with the development of an anti-human lymphocyte globulin (ALG) at his Institute during the late 1960s. The initial successful treatment of a small number of patients culminated in the co-treatment of the first successfully heart-transplanted patient in Capetown, South Africa (successful reversal with ALG of an acute allograft rejection). Walter Brendel was a pioneering personality whose work has laid a wide platform for the promotion of interdisciplinarily conducted innovative research programs in various domains of translational science and medicine. Among the many innovative achievements, the most notable are: discovery of involvement of the alternative pathway of complement activation in hyperacute xenograft rejection; induction of immunological tolerance to horse IgG as a means to prevent anaphylactic reactions during ALG therapy; development and clinical implementation of the extracorporeal shock wave lithotripsy for extracorporeal destruction of renal and ureteral calculi. The legacy of Brendel continues with the foundation of the Walter-Brendel Kolleg für Transplantationsmedizin (i.e., the German Transplant School for Transplantation Medicine), which has been held annually since 1994.

Land, W. G. (2024). Walter Brendel and the dawn of transplantation research in Germany. Frontiers in Transplantation, 3, 1461399. https://www.frontiersin.org/journals/transplantation/articles/10.3389/frtra.2024.1461399/full#h1



Comments


© 2021 Deutsche Akademie für Transplantationsmedizin e.V.

Marchioninistr. 15, 81377 München

Tel: 089-4400-72600

  • White Twitter Icon
bottom of page